BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28427357)

  • 1. Haplotype of non-synonymous mutations within IL-23R is associated with susceptibility to severe malaria anemia in a P. falciparum holoendemic transmission area of Kenya.
    Munde EO; Raballah E; Okeyo WA; Ong'echa JM; Perkins DJ; Ouma C
    BMC Infect Dis; 2017 Apr; 17(1):291. PubMed ID: 28427357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production.
    Ouma C; Davenport GC; Were T; Otieno MF; Hittner JB; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
    Hum Genet; 2008 Dec; 124(5):515-24. PubMed ID: 18972133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya.
    Munde EO; Okeyo WA; Raballah E; Anyona SB; Were T; Ong'echa JM; Perkins DJ; Ouma C
    BMC Infect Dis; 2017 Apr; 17(1):289. PubMed ID: 28427365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum.
    Kisia LE; Kempaiah P; Anyona SB; Munde EO; Achieng AO; Ong'echa JM; Lambert CG; Chelimo K; Ouma C; Perkins DJ; Raballah E
    BMC Med Genet; 2019 Aug; 20(1):140. PubMed ID: 31420016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels.
    Okeyo WA; Munde EO; Okumu W; Raballah E; Anyona SB; Vulule JM; Ong'echa JM; Perkins DJ; Ouma C
    BMC Immunol; 2013 Mar; 14():15. PubMed ID: 23521898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region.
    Anyona SB; Hengartner NW; Raballah E; Ong'echa JM; Lauve N; Cheng Q; Fenimore PW; Ouma C; Lambert CG; McMahon BH; Perkins DJ
    J Hum Genet; 2020 Jan; 65(2):99-113. PubMed ID: 31664161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic variability in the 3' untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malaria.
    Ong'echa JM; Raballah EO; Kempaiah PM; Anyona SB; Were T; Davenport GC; Konah S; Vulule JM; Ouma C; Hittner JB; Perkins DJ
    BMC Genet; 2011 Aug; 12():69. PubMed ID: 21819616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human NCR3 gene variants rs2736191 and rs11575837 alter longitudinal risk for development of pediatric malaria episodes and severe malarial anemia.
    Onyango CO; Cheng Q; Munde EO; Raballah E; Anyona SB; McMahon BH; Lambert CG; Onyango PO; Schneider KA; Perkins DJ; Ouma C
    BMC Genomics; 2023 Sep; 24(1):542. PubMed ID: 37704951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.
    Anyona SB; Kempaiah P; Raballah E; Ouma C; Were T; Davenport GC; Konah SN; Vulule JM; Hittner JB; Gichuki CW; Ong'echa JM; Perkins DJ
    Infect Immun; 2011 Dec; 79(12):4923-32. PubMed ID: 21969001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population.
    Ogola GO; Ouma C; Jura WG; Muok EO; Colebunders R; Mwinzi PN
    BMC Infect Dis; 2014 Jun; 14():316. PubMed ID: 24912586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children.
    Ouma C; Davenport GC; Garcia S; Kempaiah P; Chaudhary A; Were T; Anyona SB; Raballah E; Konah SN; Hittner JB; Vulule JM; Ong'echa JM; Perkins DJ
    Hum Genet; 2012 Feb; 131(2):289-99. PubMed ID: 21818580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality.
    Kempaiah P; Anyona SB; Raballah E; Davenport GC; Were T; Hittner JB; Ong'echa JM; Perkins DJ
    Hum Genet; 2012 Aug; 131(8):1375-91. PubMed ID: 22570109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in Kenyan children.
    Achieng AO; Hengartner NW; Raballah E; Cheng Q; Anyona SB; Lauve N; Guyah B; Foo-Hurwitz I; Ong'echa JM; McMahon BH; Ouma C; Lambert CG; Perkins DJ
    EBioMedicine; 2019 Jul; 45():290-302. PubMed ID: 31278068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.
    Ouma C; Keller CC; Davenport GC; Were T; Konah S; Otieno MF; Hittner JB; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
    Infect Immun; 2010 Jan; 78(1):453-60. PubMed ID: 19884328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods.
    Ong'echa JM; Davenport GC; Vulule JM; Hittner JB; Perkins DJ
    Infect Immun; 2011 Nov; 79(11):4674-80. PubMed ID: 21859849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the IL-17F, IL-23 and IL-23R on susceptibility and phenotype of systemic lupus erythematosus.
    Paradowska-Gorycka A; Sowinska A; Stypinska B; Grobelna MK; Walczyk M; Olesinska M; Piotrowski P; Jagodziński PP
    Autoimmunity; 2016 Sep; 49(6):373-382. PubMed ID: 27320770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production.
    Ouma C; Davenport GC; Awandare GA; Keller CC; Were T; Otieno MF; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
    J Infect Dis; 2008 Oct; 198(8):1219-26. PubMed ID: 18781863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T-cell expression of IFN-γ and IL-17 in pediatric malarial anemia.
    Raballah E; Kempaiah P; Karim Z; Orinda GO; Otieno MF; Perkins DJ; Ong'echa JM
    PLoS One; 2017; 12(4):e0175864. PubMed ID: 28426727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the Fc gamma receptor IIIA and Toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon levels.
    Munde EO; Okeyo WA; Anyona SB; Raballah E; Konah S; Okumu W; Ogonda L; Vulule J; Ouma C
    Infect Immun; 2012 Dec; 80(12):4435-43. PubMed ID: 23045477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya.
    Kisia LE; Cheng Q; Raballah E; Munde EO; McMahon BH; Hengartner NW; Ong'echa JM; Chelimo K; Lambert CG; Ouma C; Kempaiah P; Perkins DJ; Schneider KA; Anyona SB
    Trop Med Health; 2022 Jun; 50(1):41. PubMed ID: 35752805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.